The Effect of Shorter Treatment Regimens for Hepatitis C on Population Health and Under Fixed Budgets

BACKGROUND: Direct acting antiviral hepatitis C virus (HCV) therapies are highly effective but costly. Wider adoption of an 8-week ledipasvir/sofosbuvir treatment regimen could result in significant savings, but may be less efficacious compared with a 12-week regimen. We evaluated outcomes under a c...

Descripción completa

Detalles Bibliográficos
Autores principales: Morgan, Jake R, Kim, Arthur Y, Naggie, Susanna, Linas, Benjamin P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767946/
https://www.ncbi.nlm.nih.gov/pubmed/29354660
http://dx.doi.org/10.1093/ofid/ofx267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767946/
https://www.ncbi.nlm.nih.gov/pubmed/29354660
http://dx.doi.org/10.1093/ofid/ofx267

Ejemplares similares